National Natural Science Foundation of China under
Grant 12061071; in part by the Higher Education of
Xinjiang Uygur Autonomous Region under Grant
XJEDU2020Y003, and XJEDU2019Y006; in part by
the Major Science and Technology Special Project of
Xinjiang Uygur Autonomous Region under Grant
2020A02001-1; in part by the Major Science and
Technology Project of Sichuan Science and
Technology Plan under Grant 2020YFQ0018; in part
by the National Innovation Training Project for
College Student under Grant 202010755021.
REFERENCES
Basu M, Bhattacharya R, Ray U, et al. Invasion of ovarian
cancer cells is induced byPITX2-mediated activation of
TGF-β and Activin-A[J]. Molecular cancer, 2015,
14(162.
Baxter R C. IGF binding proteins in cancer: mechanistic
and clinical insights[J]. Nature reviews Cancer, 2014,
14(5): 329-341.
Björk S, Hurt C M, Ho V K, et al. REEPs are membrane
shaping adapter proteins that modulate specific g
protein-coupled receptor trafficking by affecting ER
cargo capacity[J]. PloS one, 2013, 8(10): e76366.
Chan J K, Magistris A, Loizzi V, et al. Mast cell density,
angiogenesis, blood clotting, and prognosis in women
with advanced ovarian cancer[J]. Gynecologic
oncology, 2005, 99(1): 20-25.
Clough E, Barrett T. The Gene Expression Omnibus
Database[J]. Methods in molecular biology (Clifton,
NJ), 2016, 1418: 93-110.
Deng Y-J, Ren E-H, Yuan W-H, et al. GRB10 and E2F3 as
Diagnostic Markers of Osteoarthritis and Their
Correlation with Immune Infiltration[J]. Diagnostics,
2020, 10(3): 171-187.
Doheny D, Manore S G, Wong G L, et al. Hedgehog
Signaling and Truncated GLI1 in Cancer[J]. Cells,
2020, 9(9): 2114-2130.
Flyvbjerg A, Mogensen O, Mogensen B, et al. Elevated
serum insulin-like growth factor-binding protein 2
(IGFBP-2) and decreased IGFBP-3 in epithelial
ovarian cancer: correlation with cancer antigen 125 and
tumor-associated trypsin inhibitor[J]. The Journal of
clinical endocrinology and metabolism, 1997, 82(7):
2308-2313.
Friendly M. Corrgrams: Exploratory Displays for
Correlation Matrices[J]. The American Statistician,
2002, 56(4): 316-324.
Guangchuang Yu L-G W, Yanyan Han, and Qing-Yu He.
clusterProfiler: an R Package for Comparing Biological
Themes Among Gene Clusters[J]. OMICS: A Journal
of Integrative Biology, 2012, 16(5): 284-287.
Hanchuan P, Fuhui L, Ding C. Feature selection based on
mutual information criteria of max-dependency, max-
relevance, and min-redundancy[J]. IEEE Transactions
on Pattern Analysis and Machine Intelligence, 2005,
27(8): 1226-1238.
Hedditch E L, Gao B, Russell A J, et al. ABCA Transporter
Gene Expression and Poor Outcome in Epithelial
Ovarian Cancer[J]. JNCI: Journal of the National
Cancer Institute, 2014, 106(7): dju149.
Jayson G C, Kohn E C, Kitchener H C, et al. Ovarian
cancer[J]. The Lancet, 2014, 384(9951): 1376-1388.
KROEGER D R, MILNE K, NELSON B H. Tumor-
Infiltrating Plasma Cells Are Associated with Tertiary
Lymphoid Structures, Cytolytic T-Cell Responses, and
Superior Prognosis in Ovarian Cancer[J]. Clinical
cancer research: an official journal of the American
Association for Cancer Research, 2016, 22(12): 3005-
3015.
Landskron J, Helland Ø, Torgersen K M, et al. Activated
regulatory and memory T-cells accumulate in
malignant ascites from ovarian carcinoma patients [J].
Cancer Immunology, Immunotherapy, 2015, 64(3):
337-347.
Lee W, Ko S Y, Mohamed M S, et al. Neutrophils facilitate
ovarian cancer premetastatic niche formation in the
omentum [J]. The Journal of experimental medicine,
2019, 216(1): 176-194.
Lee E J, Mircean C, Shmulevich I, et al. Insulin-like growth
factor binding protein 2 promotes ovarian cancer cell
invasion[J]. Molecular cancer, 2005, 4(1): 7-13.
Marvi-Khorasani H, Usefi H. Feature Clustering Towards
Gene Selection[C]. In Proc. of the 18th IEEE
International Conference on Machine Learning and
Applications (ICMLA). Dec 16-19, 2019, Boca Raton,
FL, USA, pp: 1466-1469.
Nieto M A, Huang R Y, Jackson R A, et al. EMT: 2016[J].
Cell, 2016, 166(1): 21-45.
Prat M, Le Naour A, Coulson K, et al. Circulating
CD14(high) CD16(low) intermediate blood monocytes
as a biomarker of ascites immune status and ovarian
cancer progression[J]. Journal for immunotherapy of
cancer, 2020, 8(1): e000472.
Pyragius C E, Fuller M, Ricciardelli C, et al. Aberrant lipid
metabolism: an emerging diagnostic and therapeutic
target in ovarian cancer[J]. International journal of
molecular sciences, 2013, 14(4): 7742-7756.
Renvoisé B, Malone B, Falgairolle M, et al. Reep1 null
mice reveal a converging role for hereditary spastic
paraplegia proteins in lipid droplet regulation[J].
Human molecular genetics, 2016, 25(23): 5111-5125.
Ritchie M E, Phipson B, Wu D, et al. limma powers
differential expression analyses for RNA-sequencing
and microarray studies[J]. Nucleic Acids Research,
2015, 43(7): e47.
Sato E, Olson S H, Ahn J, et al. Intraepithelial CD8+ tumor-
infiltrating lymphocytes and a high CD8+/regulatory T
cell ratio is associated with favorable prognosis in
ovarian cancer[J]. Proceedings of the National
Academy of Sciences of the United States of America,
2005, 102(51): 18538-18543.
Siegel R L, Miller K D, Fuchs H E, et al. Cancer statistics,
2022[J]. CA: A Cancer Journal for Clinicians, 2022,
72(1): 7-33.